Related Experiment Video
Updated: Sep 8, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence
Fan Zhang1,2,3, Yuan Wang1,2, Luyang Zhang1,2
1Xuanwu Hospital Capital Medical University, Beijing, China.
Abstract:
The dysfunction of the cellular endolysosomal pathway, such as in lysosomal storage diseases, can cause severe musculoskeletal disorders. However, how endolysosomal dysfunction causes musculoskeletal abnormalities remains poorly understood, limiting therapeutic options. Here, we report that CHMP5, a member of the endosomal sorting complex required for transport (ESCRT)-III protein family, is essential to maintain the endolysosomal pathway and regulate bone formation in osteogenic lineage cells. Genetic ablation of Chmp5 in mouse osteogenic cells increases bone formation in vivo and in vitro. Mechanistically, Chmp5 deletion causes endolysosomal dysfunction by decreasing the VPS4A protein, and CHMP5 overexpression is sufficient to increase the VPS4A protein. Subsequently, endolysosomal dysfunction disturbs mitochondrial functions and increases mitochondrial ROS, ultimately resulting in skeletal cell senescence. Senescent skeletal cells cause abnormal bone formation by combining cell-autonomous and paracrine actions. Importantly, the elimination of senescent cells using senolytic drugs can alleviate musculoskeletal abnormalities in Chmp5 conditional knockout mice. Therefore, our results show that cell senescence represents an underpinning mechanism and a therapeutic target for musculoskeletal disorders caused by the aberrant endolysosomal pathway, such as in lysosomal storage diseases. These results also uncover the function and mechanism of CHMP5 in the regulation of cell senescence by affecting the endolysosomal-mitochondrial pathway.
Insights
CHMP5 protein dysfunction disrupts the endolysosomal pathway, leading to skeletal cell senescence and bone abnormalities. Eliminating senescent cells offers a potential therapy for these musculoskeletal disorders.
Area of Science:
- Cell Biology
- Molecular Biology
- Skeletal Biology
Background:
- Endolysosomal pathway dysfunction, observed in lysosomal storage diseases, is linked to musculoskeletal disorders.
- The precise mechanisms connecting endolysosomal dysfunction to skeletal abnormalities are not well understood, hindering therapeutic development.
Purpose of the Study:
- To investigate the role of CHMP5 in maintaining the endolysosomal pathway and regulating bone formation.
- To elucidate the molecular mechanisms by which endolysosomal dysfunction leads to musculoskeletal abnormalities.
Main Methods:
- Genetic ablation of CHMP5 in mouse osteogenic cells.
- In vivo and in vitro bone formation assays.
- Analysis of endolysosomal and mitochondrial function, reactive oxygen species (ROS) levels, and cell senescence.
- Evaluation of senolytic drug efficacy in CHMP5 knockout mice.
Main Results:
- Genetic deletion of CHMP5 in osteogenic cells enhanced bone formation.
- CHMP5 deficiency led to endolysosomal dysfunction, decreased VPS4A protein, impaired mitochondrial function, and increased mitochondrial ROS.
- These cellular changes resulted in skeletal cell senescence, causing abnormal bone formation.
- Elimination of senescent cells using senolytic drugs ameliorated musculoskeletal abnormalities in CHMP5 knockout mice.
Conclusions:
- CHMP5 is crucial for endolysosomal pathway integrity and normal bone development.
- Endolysosomal dysfunction, mediated by CHMP5 loss, drives skeletal cell senescence via mitochondrial impairment.
- Cellular senescence is a key mechanism underlying musculoskeletal disorders associated with endolysosomal pathway defects and presents a therapeutic target.
More Related Videos
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Replicative Cell Senescence
Export of Misfolded Proteins out of the ER
Osteoclasts in Bone Remodeling
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
Telomeres and Telomerase